Every woman deserves
to bloom.
We work to raise awareness, expand access to screening, and support women facing breast, ovarian, and cervical cancer — because early detection saves lives.
Early Detection
Regular screening dramatically improves survival rates. We help women understand when and how to get checked.
Community Support
No woman should face a cancer diagnosis alone. We build networks of peer support, information, and guidance.
Education & Awareness
We translate complex medical information into clear, accessible guidance that empowers women to act.
Advocacy
We advocate for equitable access to screening, treatment, and specialist care for all women.
Women will be diagnosed with breast cancer in their lifetime — the most common cancer in women worldwide
Survival rate for breast cancer when detected early (Stage I) — compared to 26% at Stage IV
A woman is diagnosed with a gynaecological cancer somewhere in Europe every four minutes
We believe knowledge is the first step toward survival.
Bloom Foundation was established to bridge the gap between medical information and the women who need it most. We work with oncologists, gynaecologists, nurses, and community advocates to ensure that no woman faces a cancer diagnosis unprepared.
Our programmes span awareness campaigns, free screening access initiatives, patient navigation support, and peer mentorship — all built around one principle: earlier is better.
- Clear, medically-reviewed information on all three gynaecological cancers
- Practical guidance on screening schedules and when to see a doctor
- Support networks connecting women with shared experiences
- Advocacy for equitable access across income and geography
The three cancers we focus on
Understanding the differences between breast, ovarian, and cervical cancer is essential for early action. Each has distinct symptoms, risk factors, and screening pathways.
Breast Cancer
The most common cancer in women globally. Abnormal cells in breast tissue that grow uncontrollably. Highly treatable when found early.
- Annual mammogram from age 40–45 (or earlier with risk factors)
- Monthly self-examination recommended
- 90%+ survival rate at Stage I
Ovarian Cancer
Often called the "silent cancer" — symptoms are subtle and easy to mistake for other conditions. Early detection is challenging but possible.
- No standard screening test — symptom awareness is critical
- Watch for persistent bloating, pelvic pain, feeling full quickly
- Genetic testing (BRCA) for high-risk women
Cervical Cancer
Almost entirely preventable through HPV vaccination and regular Pap smears. One of the most successfully screened-for cancers in women.
- HPV vaccine recommended for girls aged 9–14 (up to 26)
- Pap smear every 3 years from age 21–65
- Over 90% preventable with regular screening
Programmes making a difference
From awareness campaigns to patient navigation, our work reaches women at every stage — before, during, and after a diagnosis.
Know Your Body Campaign
A nationwide awareness initiative helping women understand warning signs and take action before symptoms become urgent.
Free Screening Access
Partnering with clinics to provide subsidised mammograms, Pap smears, and HPV tests to women without insurance or access.
Peer Navigation Programme
Connecting newly diagnosed women with trained peer navigators — women who have been through treatment and can guide others.
When did you last have a screening?
Regular screening is the most powerful thing you can do. Most cancers caught early are highly treatable. Don't wait for symptoms — schedule your check-up now.
Latest from Bloom
Research updates, patient stories, event announcements, and advocacy news.
New EU directive on cancer screening published
The European Council has adopted updated recommendations expanding free cervical and breast screening for all women aged 25–69. What it means for you.
Read more
HPV vaccination rates rise across Central Europe
A new report shows cervical cancer cases declining in countries with high HPV vaccination coverage. Bloom Foundation's advocacy role in expanding access.
Read more
AI-assisted mammography reduces missed diagnoses by 40%
A landmark study shows AI-assisted reading of mammograms significantly improves detection rates. We explain what this means for your next screening.
Read more